- Opportunity and Forecast, 2016 - 2025
Poultry probiotics are microorganisms added to meals to improve production of meat and eggs from poultry animals. They are also used for prevention of diseases and pathogens that cause reduction in poultry performance. Microorganisms from various genera such as, Bacillus, Lactobacillus, Streptococcus, Bifidobacterium, Enterococcus, Saccharomyces, Candida, and others, are used as probiotics to benefit broiler performance. Probiotics are also preferred to improve feed performance at lower costs. In addition, their use in poultry applications prevents early mortality, scouring, appetite loss, improper digestion, poor nutrient absorption, and others. Improvement in egg production & quality, intestinal microbial balance, egg albumen quality, nutrients absorption, and others are few benefits provided by poultry probiotics.
Ban on antibiotics use as growth-promoting agents, owing to issues such as development of drug-resistant bacteria, drug residues in bird bodies, and microflora imbalance, is expected to drive the market growth. In addition, increase in meat production and consumption in Asia-Pacific and North America is expected to present new avenues for growth in the industry.
The global poultry probiotics market is segmented based on product type and geography. Based on product type, the market is bifurcated into power feed supplements and liquid feed supplements. Geographically, it is divided into Europe, North America, Asia-Pacific, Latin America, and Middle East and Africa.
Major companies operating in the industry include Danone, Nestle, Yakult, and Chr. Hansen, BioGaia, Danisco, General Mills, Arla Foods, DuPont, Bilogics AB, DSM, and ConAgra. These companies have formulated strategies, such as partnerships, joint ventures, collaborations, expansion, new product launches, mergers & acquisitions, and others, to strengthen their position and gain a strong foothold in the market.
The United States Amniotic Membrane Market accounted for $189 million in 2012 and is expected to reach $722 million by 2022, registering a CAGR of 13.6% from 2017 to 2022. Read More >>